78 results about "Neurosis" patented technology

Compositions based on hydrogenated pyrido[4,3-b]indoles (variants) of formula (1) or formula (2): are provided, as are methods and kits using those compositions for the treatment of anxiety or mood disorders characterized by stresses, anxiety, neuroses, obsessive fears and their consequences.

The invention discloses a medical combination for treating pulmonary heart disease and rheumatic heart disease and the preparation method thereof; the invention is prepared by peach kernel, safflower, angelica, charles abraham, Szechwan Lovage Rhizome, red peony root, achyranthes root, balloonflower root, bupleurum, citrus aurantium, and licorice. The medical combination of the invention has the efficacy of activating blood, promoting qi and ending pains, mainly for the treatment of pulmonary heart disease, rheumatic heart disease, the chest pain and headache caused by the clotted blood and the unsmooth blood flow in the chest, and also for coronary angina pectoris, chest contusion, rib chondritis chest pain, neurosis, deprementia of the concussion of brain sequela, dizziness headache, and other diseases. The invention has the advantages of simple formula, easy production, convenient taking by the patients, obvious efficacy, and wide application value.

Oligomers and polymer compositions are provided which comprise GHB and produce GHB after administration in vivo. Devices for the storage and delivery of these polymers and oligomers are also provided. These oligomers and polymer compositions are useful in a variety of applications. The compositions can be used therapeutically, for example, in the treatment of patients with narcolepsy, chronic schizophrenia, catatonic schizophrenia, atypical psychoses, chronic brain syndrome, neurosis, alcoholism, drug addiction and withdrawal, Parkinson's disease and other neuropharmacological illnesses, hypertension, ischemia, circulatory collapse, radiation exposure, cancer, and myocardial infarction. Other uses for the compositions include anesthesia induction, sedation, growth hormone production, heightened sexual desire, anorectic effects, euphoria, smooth muscle relaxation, muscle mass production, and sleep, including rapid eye movement sleep. In a still further embodiment, the oligomers and polymers may be used to produce absence seizures.

The invention relates to a traditional Chinese medicine for treating chronic gastrointestinal diseases to effectively solve treatment medicine use problems for the chronic gastrointestinal diseases. A technical scheme to solve the problems is that the traditional Chinese medicine comprises 6-20g of radix bupleuri, 6-20g of Radix Scutellariae, 6-15g of cassia twig, 6-30g of white peony root, 6-20gof Radix Codonopsis, 6-30g of dry ginger, 3-15g of Radix aconiti lateralis preparata, 6-15g of Rhizoma Atractylodis Macrocephalae, 10-30g of radix rehmanniae, 6-20g of donkey-hide gelatin beads, 10-30g of Poria cocos, 6-20g of turtle shell, 10-30g of calcined oyster shell and 6-15g of honey-fried licorice root. The traditional Chinese medicine can be prepared into a decoction, a pulvis, a tablet,a pill or a capsule for administration through adopting routine methods according to the need, and the traditional Chinese medicine which can effectively treat various chronic gastrointestinal diseases of chronic gastritis, gastric ulcer, duodenal ulcer, stomach dilatation, stomach ptosis, neurosis, ulcerative colitis, cholecystitis, bile reflax gastritis and the like has the advantages of good curative effect, no toxic side effect, and safety and reliability.

The invention discloses a medicine combination used for treating coronary heart disease angina and epigastric pain and a preparation method thereof; the medicine combination is mainly made from snakegourd fruit, salvia, bulbus allii macrostemi, pinellia ternata, rhizoma corydalis, tangerine peel, citrus aurantium, cassia twig, villous amomum fruit and sandalwood. The medicine combination of the invention has the function of activating Yang and eliminating phlegm, and promoting blood circulation and relieving congestion and is mainly indicated for chest distress of phlegm obstruction and blood stasis, angina pectoris and stomachache; the medicine combination can also be used for treating chronic gastritis, gastroduodenal ulcer, stomach neurosis, chronic hepatitis, and chronic pancreatitis. The medicine combination of the invention is characterized by simple prescription, convenient production, convenient administration for patients and remarkable curative effects, thus presenting a wide application value.

The present invention discloses a kind of neurosis treating medicine composition, which is prepared bupleurum root, kudzu vine root, corydalis tuber, white peony root, cassia twig and other nine kinds of Chinese medicinal materials in certain weight proportion. The medicine composition may be used in preparing different preparations for treating different types of neurosis, and has high curative effect and fast acting. The present invention is suitable for industrial production.

The present invention relates to a Chinese medicine Yangxin Anmian capsule preparation with the functions of nourishing yin, clearing away heat, nourishing heart and tranquilizing mind for curing the diseases of neurasthenia, neurosis, vexation and sleeplessness, profuse dreaming, dizzy head, tinnitus, limp aching lumbus and knees, etc. Said Chinese medicine capsule preparation is made up by using 10 Chinese medicinal materials of fresh deer's heart, fresh deer's blood, poria, spiny jujube kernel, longan flesh, schisandra berry and others and adopting traditional Chinese medicine preparation process.

The invention discloses a pharmaceutical composition for safely and effectively treating insomnia and a preparation method thereof, and the active ingredients of the composition are prepared by extracting more than ten medicinal materials of platycladi seed, radix salviae miltiorrhizae, raw nacre, cassia bark, drug sweetflag rhizome, Szechuan lovage rhizome, thinleaf milkwort root-bark, amber, radix rehmanniae preparata, common macrocarpium fruit, parslane herb, tuber fleeceflower stem, oriental waterplantain rhizome, tree peony bark, Indian buead, stir-fried date seed and the like. The unique medicinal active ingredients in the pharmaceutical composition have the efficacies of tranquilizing and allaying excitement, conditioning nerves and enhancing neurological function, have strong efficacies for neural fatigue, mental depression, neurosis, vegetative nerve functional disturbance and the like and particularly have the unique efficacies for treating intractable insomnia.

The invention belongs to the medicine field, in particular to an application of a microbiological preparation for preventing or treating diabetes, in particular 2-type diabetes and related symptoms thereof. The related symptoms comprise adiposity, insulin resistance, hyperinsulinemia, hyperlipoidemia, atherosclerosis, hyperuricemia, the caused metabolism syndrome related symptoms containing uarthritis, and the like, regression neurosis containing Alzheimer's disease, Parkinson's disease, and the like, and similar symptoms. More concretely, the active ingredient of the microbiological preparation is a nonpathogenic germ for expressing active phenylalanine deaminase and / or phenylalnine ammonialyase, and the starting bacterial strain of the nonpathogenic germ is a natural bacterium or a genetic engineering bacterium.

The present invention is oryzanol liposome with high absorption, high bioavailability and high stability and its preparation. The oryzanol liposome or oryzanol liposome precursor is prepared with oryzanol and phosphatide, cholesterol, supporting agent and other supplementary material. It has phosphatide / medicine weight ratio of 0.1-40, and is prepared through ethanol injecting process, film dispersion process, inverse evaporation process, extruding process or mechanical process. The supporting agent may be sorbitol, mannitol, cane sugar, etc. and has ratio to phosphatide of 0.01-400. The oryzanol liposome can act selectively on the autonomic nerve system of interbran and the center of endocrine system to improve autonomic nerve system, endocrine system and psychonerve. It is suitable for treating neurosis, climacteric syndrome, etc., and may be used in the assisting treatment of vascular headache and cerebral concussion sequelae.

The invention discloses a Chinese medicinal composition for relieving mind and calming nerve, which is characterized in that: the Chinese medicinal composition is mainly prepared from the following components in part by weight: 7 to 20 parts of arisaema cum bile, 20 to 35 parts of snakegourd fruit, 7 to 20 parts of red orange, 6 to 15 parts of grassleaf sweelflag rhizome, 8 to 18 parts of rhubarb, 16 to 25 parts of figwort root, 6 to 15 parts of golden thread, 20 to 35 parts of Drgon's bones and 6 to 15 parts of Indian buead. The Chinese medicinal composition can recuperate visceral functions of a human body, and balance yin and yang to fulfill the aims of treating both principal and secondary aspect of disease and strengthening the vitality. The Chinese medicinal composition can well control diseases such as paranoid type, insomnia and dreamful sleep, phobic anxiety, melancholy, acoasma, mania and restlessness, neurosis and acute and chronic schizophrenia caused by various reasons, has obvious treatment effect and has the total effective rate of 99.4 percent.

Disclosed is a Chinese medicament for treating heart neurosis and its preparing process, wherein the raw materials include poria with hostwood, cinnabar, scrophularia root, bamboo leaves, pilose asiabell root, amber, astragalus root, oyster shell, pinellia tuber, cardamom, licorice root, polygala root, prepared rehmannia root, Chinese angelica root and baikal skullcap root. The preparing process consists of disintegrating cinnabar and oyster into fines, making medicinal powders and mixing homogeneously.

The invention discloses depression-dispelling nerve-soothing granules and a preparation method for an oral solution of the same. The depression-dispelling nerve-soothing granules are prepared by the following components by weight: 180-220 parts of ginseng, 280-320 parts of spina date seed, 180-220 parts of prepared rehmannia root, 90-110 parts of multiflower knotweed vine, 90-110 parts of platycladi seed, 135-165 parts of fushen, 90-110 parts of pearl powder, 85-95 parts of albizia flower, 90-110 parts of polygala tenuifolia, 75-85 parts of lotus plumule, 85-95 parts of radix ophiopogonis, 75-85 parts of rose, 55-65 parts of radix scrophulariae and 45-55 parts of fructus amomi. The depression-dispelling nerve-soothing granules are mainly used for clinically treating the symptoms of dysphoria and insomnia, palpitation and uneasiness, nerve tiredness and amnesia, feverishness in palms and soles, dryness in pharynx and mouth, dry stool, reddened tongue with less moss and thready rapid pulse. The granules achieve a remarkable effect in treatment of insomnia, neurosis and the like. The granules can further improve the memory of the body while soothing the nerves and assisting sleep.

The invention discloses a medicine for treating neurosis and a preparation method thereof. The medicine provided in the invention comprises the following raw materials: 30 parts by weight of vinegar-processed tortoiseshell, 5 parts by weight of gen-seng, 15 parts by weight of longan aril, 20 parts by weight of lily, 20 parts by weight of fried Semen ziziphi jujubae, 15 parts by weight of polygala root, 10 parts by weight of grass-leaved sweetflag rhizome and 10 parts by weight of curcuma tuber. The preparation method for the medicine with a capsule form comprises the following steps: extracting volatile oil from grass-leaved sweetflag rhizome by the method of steam distillation, filtering the aqueous solution, and respectively storing the volatile oil and the filtrate with containers for subsequent use; crushing vinegar-processed tortoiseshell and gen-seng into fine powder; decocting the rest 5 raw materials, namely, longan aril, lily, fried Semen ziziphi jujubae, polygala root and curcuma tuber, and herb residues of grass-leaved sweetflag rhizome with water twice, filtering the decoction, combining the filtrates, standing the combined filtrate, carrying out filtrating, concentrating the filtrate under reduced pressure, spraying the filtrate to form powder, adding gen-seng and tortoiseshell powder, evenly mixing the powder, carrying out granulation, drying and cooling the granules, uniformly spraying the volatile oil into the granules, and filling the granules into capsules. The medicine provided in the invention reduces side effects in treating neurosis with western medicines and has good curative effects.

The invention discloses application of all-cannabinoid in preparation of drugs for treating depression. The all-cannabinoid is prepared by uniformly mixing, by weight, 0.3-99.7 parts of an industrial hemp seed extract with 99.7-0.3 parts of industrial cannabinoids. The all-cannabinoid has the obvious relieving effect on the symptoms such as secondary learning memory deterioration of the depression and can be used for preparing the drugs for treating various depression symptoms including endogenous depression, reactive depression, latent depression, secondary depression caused by drugs, climacteric or postnatal depression, depression induced by cerebral trauma or stroke, diabetes-complicated depression and depressive neurosis and used for preparing the drugs for treating the symptoms such as secondary learning memory deterioration and anhedonia which are caused by the depression, and the effect of the all-cannabinoid is better than that of cannabidiol. The all-cannabinoid can be prepared into the clinical drugs of various dosage forms through a conventional preparation method and is convenient to use.

The present invention relates to the compounds of the formula (I) and salts thereof (all the symbols are the same meanings as described in the specification). The compounds of the formula (I) possess inhibitory activity of N-type calcium channel, so they are useful as drug for prevention and / or treatment of cerebral infarct, transient ischemic attack, encephalomyelopathy after cardiac operation, spinal angiopathy, hypertension with stress, neurosis, epilepsy, asthma and pollakiuria etc. or agent for the treatment of pain

The invention relates to a composition containing fish eyes, theanine and gamma-aminobutyric acid and capable of alleviating asthenopia, belongs to the field of medicine health, and provides a composition capable of alleviating asthenopia. The active components of the composition comprise fish eyeball tissues or an extract thereof, fish eye socket tissues and an extract thereof, the theanine and the gamma-aminobutyric acid. Test results in crowds prove that the composition has effect on eye local symptoms of asthenopia, can obviously improve the neurosis symptoms caused by asthenopia of different degrees, such as unconcentrated attention, and reduced memory, is notable in effect of alleviating asthenopia and has broad market development prospect.

The present invention relates to a zishuiqinggan oral liquid preparation which is prepared from 11 Chinese traditional medicines including rehmanniae vaporata etc., and a method for preparing the same. The preparation is prepared from mixed extract (including extractum or dry powder and volatile oil) including rehmanniae vaporata, angelica, zaoren, cornus officinalis, tuckahoe, yarm, bupleurum, capejasmine, cortex moutan, americanwater plantain as raw materials, and acceptable carrier or excipient as substrate in medicine by conventional process. The preparation has good property of nourishing yin and blood, dispersing stagnant liver and clearing away heat for treating yin deficiency and liver depression, hypochondrial distending pain, gastric cavity pain, dry throat with a bitter taste, red tongue and less tongue coating, pulse deficiency and wiry or thin soft. The medicine preparation is used for treating chronic hepatitis, neurasthenia, climacteric syndrome, neurosis, masculine sterility and hypertension in clinical.

The invention discloses a neurosis screening scale system which comprises: a user management module used for modifying and storing user information, the user information comprises doctor information and patient information, and the user management module associates the doctor information with the corresponding patient information; the scale building module that is used for providing functions of autonomously building a scale and adding, deleting and modifying the content of the scale for the doctor ID; the scale management module that is used for providing a general scale and storing the general scale in the scale management module for the doctor ID or the patient ID to obtain, and the scale management module is used for storing the scale autonomously created by the doctor ID; the scale questionnaire module that provides an input function, and the patient ID can input options corresponding to questions; and the data analysis module that is used for acquiring options input by the patient ID in the scale questionnaire module and scores corresponding to the scale options by a user, and acquiring a calculation formula of the scale, so as to calculate disease scores of the patient ID and evaluation results corresponding to the scores.

Use of Human Chorionic Gonadotropin (hCG) by oral-sublingual or injectable route for the treatment of several food disorders, as an appetite-suppressant agent, food compulsiveness as well as all of those pathologies related to hunger and / or appetite modifications, including overweight, obesity, anorexia, bulimia, emotional hyperphagia, without excluding other pathologies associated to overingestion or reduced ingestion. It also includes its use for the treatment of behavior disorders associated with an increased ingestion, either behavior disorders, neurosis, borderline personality disorders or psychosis, without excluding other psychosomatic disorders.

The invention discloses a capsule for treating neurosis intestinal obstruction after gastrointestinal surgery and a preparation method thereof, and aims to solve the problem of treatment of the neurosis intestinal obstruction after abdominal surgery. The capsule is characterized in that the preparation methods includes (1), performing water vapor distillation on gastrodia elata BI, alyxia sinensis and barks or roots of litterflower stringbush to extract volatile oil for standby application, and leaving herb residues for standby application; (2), smashing gecko and burnt rice sprouts into fine powder for standby application; (3), uniformly mixing aspongopus, timonius arboreus, jasminum grandiflorum, allium victorialis, ternate buttercup roots, Chinese starjasmine stems and cassia twigs with the herb residues obtained in step 1, performing alcohol extraction for twice, merging alcohol extracts for twice, filtering, recovering alcohol and performing decompression concentration to form extractum; (4), adding the fine powder obtained in step 2 in the extractum obtained in step 3, mixing well, drying at 60 DEG C, smashing into fine powder, adding polysorbate-80 to form particles, drying, granulating, spraying the volatile oil obtained in step 1, mixing well, and filling to obtain the capsule. Clinical tests show that the capsule has advantages of good treatment effect and high safety and is worthy of clinical application and popularization.

The invention discloses a traditional Chinese medicine composition for treating bundle branch block and related heart diseases. The traditional Chinese medicine is made by combining Chinese herbal formulas of monkshood, dried radix rehmanniae, polygonum multiflorum, scrophulariae, salviae miltiorrhizae, red peony roots, raw hawthorns, rhizoma chuanxiong, cassia twig, raw fossil fragments, raw oyster shells, earthworms, amomum, rhizoma alismatis, astragalus, ephedra, radix glycyrrhizae, pulp of cornus and the like. The traditional Chinese medicine composition integrates tonifying and dredging and has the effects on promoting blood circulation and removing blood stasis, promoting circulation of qi and blood, enhancing metabolism and repairing important viscera trauma, and promoting metabolism and regeneration of brain cells, liver cells and myocardial cells. Heart system diseases comprise tachycardia, bradycardia, premature beat, atrial fibrillation and flutter, atrioventricular block, branch conduction block, sick sinus syndrome, pre-excitation syndrome, heart failure, carditis, pericarditis, part of neurosis and the like. The tradition Chinese medicine composition has the miracle effect on treating stagnation of the heart-blood, chest obstructions and chest pains and has the good curative effects on repairing rheumatic heart disease cardiac muscle valves and treating congenital heart disease valve defects and cardiac muscle inferior myocardial infarction.

The invention discloses a method for extracting features of neurosis based on a graph theory and machine learning. The method comprises the steps: firstly, constructing a cerebral functional network of a body dimension and an emotion dimension in case of the neurosis based on EEG data, and separately selecting a phase lag index and a weighted phase lag index as measures of a network middle edge by taking 62 channels as network nodes; and extracting network topological attributes--global efficiency corresponding to the two indexes, carrying out fusing so as to obtain eigenvectors for identifying the body dimension and the emotion dimension, and carrying out classification by using a machine-learning classification model. Network abnormal link positions of two dimensions can be positioned by mapping the cerebral functional network corresponding to the features to a 3D brain model. According to the method, a marker can be further provided for identification on the neurosis, and targets for further researching diseases are provided.

The invention provides an application of a traditional Chinese medicine composition in preparing a medicine for treating psychoneurosis. The psychoneurosis is also known as neurosis; and the manifestations of the syndrome are mainly chest distress, cardiopalmus, short breath, thoracalgia or gastralgia, hiccup, and physical and emotional handicaps such as anxiety, repression, poor sleep quality and so on. The traditional Chinese medicine composition can effectively improve the manifestations.

The invention provides a pure traditional Chinese medicine preparation for treating neurosis, which comprises the following raw material herbs by weight: 1-3 parts of musk, 12-20 parts of pseudo-ginseng, 12-20 parts of tortoise shell gel, 8-10 parts of tabasheer, 8-10 parts of periostracum cicadae, and 8-10 parts of amber. The preparation can be prepared into various dosage forms according to routine pharmaceutical preparation technology, such as tablets, capsules, granules, oral liquid preparations, and the like, is simple in preparation, convenient for taking, safe, free of side effects, wide in treatment scope, high in curative effect, and short in treatment course.

The invention relates to a medical care instrument of the ears and the brain, which comprises a magnetic bar, a casing and medicinal powder. The medical care instrument of the ears and the brain has the effects of dredging the channel, activating the collaterals, regulating the encephalic blood circulation and the encephalic nervous disorder, promoting blood circulation, lowering pressure, relieving convulsion, alleviating pain, diminishing inflammation, killing bacteria and the like. The invention can be used for preventing and treating the diseases of tinnitus, deafness, tympanitis, auditory vertigo, neural headache, migraine, various kinds of headache, neurosis, insomnia, cerebral insufficiency of blood supply, cerebral anoxia, cerebrovascular spasm, hypertension and the like.

The invention provides a new use of steroid total saponins extract, in particular to a use of preparation for curing heart neurosis drugs. The invention also provides a drug composition for curing heart neurosis. The inventor finds that the steroid total saponins extract has obvious function of curing heart neurosis, improving patient clinical symptoms through experimental studies. The new use has the advantages of ability to provide a new, outstanding therapeutic effect drug selection, and good economic and social benefits.

The invention relates to the field of application of traditional Chinese medicines and particularly discloses a traditional Chinese medicine for treating a patient suffering from internal medicine neurosis. The traditional Chinese medicine for treating internal medicine neurosis is prepared by mixing raw materials comprising folium polygoni tinctorii, figs, Chinese soapberry fruits, common st. john's wort herb, wild chrysanthemum, discolor cinquefoil herb, lance asiabell roots, watermelon peel, pale butterflybush flowers, devilpepper roots, plumeria rubra, common selfheal fruit-spike, striga asiatica, saxifraga, Evodia lepta, Chinese knotweed herb and jasminum elongatum in a certain weight proportion. The traditional Chinese medicine is simple to prepare, the absorbing effect is good, the medicine efficacy lasts long, the curative effect is remarkable, the production cost is low, and the traditional Chinese medicine does not have side effects, is high in safety, and facilitates timely relief of symptoms of the patient.

The present invention discloses a kind of neurosis treating medicine composition, which is prepared bupleurum root, kudzu vine root, corydalis tuber, white peony root, cassia twig and other nine kinds of Chinese medicinal materials in certain weight proportion. The medicine composition may be used in preparing different preparations for treating different types of neurosis, and has high curative effect and fast acting. The present invention is suitable for industrial production.

The invention relates to the technical field of medicines, and discloses an application of a compound Axitinib in preparation of a medicine for treating cerebrovascular diseases and a pharmaceutical composition thereof, the compound Axitinib is N-methyl-2-[3-((E)-2-pyridine-2-yl-vinyl)-1H-indole-6-yl sulfonyl]-benzamide, and a structural formula of the compound Axitinib is shown in the specification. According to the technical scheme, the volume of focal cerebral ischemia minor acute stage cerebral infarction is obviously reduced, the neurological symptoms are remarkably improved, the cerebralnerve protection effect is achieved, and especially the good effect on cerebral ischemic diseases is achieved.